glp-1 launch NEW FOR 2026: Medicare Bridge Program Access to eligible weight-loss medications for approximately $50/month* *Eligibility and physician approval required. Starting July 1, 2026, Medicare will a new temporary program called Novo Nordisk's Wegovy pill launch

It is unknown whether SAXENDA causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1), Nonclinical Toxicology (13.1)]

Safety considerations for weight loss peptide dosing Peptide safety depends partly on accurate dosing

Microbiome & Metabolic Support: Akkermansia+

These medications, combined with lifestyle changes like a balanced diet and regular exercise, can help women regain control over their eating habits, reduce cravings, and support their overall well-being

Public figures are increasingly candid about their health journeys, including how they care for their skin through periods of change